NRIX (Nurix Therapeutics) Earnings growth in current year

Official company branding of nurixtx.com (NRIX)

The flawless performance of Nurix Therapeutics (NRIX) R&D laboratories ensures a steady pace of research. The annual EPS growth rate visualizes this efficiency, where the value 188.40 reflects the state of the profit parameter. This trend is driven by the success of the NX-5948 drug and strategic alliances. The protection of intellectual property rights for chemical platforms and the high cost of hiring rare scientists create a robust barrier to entry for competitors.

NRIX (Nurix Therapeutics, Inc.) Earnings growth in current year history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for Nurix Therapeutics (NRIX)

- share price and expert price forecast:
Fundamental valuation:NRIX Nurix Pharma
Signature product of Nurix Corp

To minimize investment risks, it is critical to track the year-over-year dynamics of net earnings per share. This annual EPS growth rate measures the percentage shift in profitability relative to the previous year, allowing for an assessment of the efficiency of Nurix Therapeutics (NRIX) R&D expenditures in PROTAC drug development and AI modeling against the operational expenses of the biopharmaceutical sector.

Direct competitors

GMAB: Net earnings per one share growth for the current year|EXEL (Exelixis Inc.) - Earnings growth in current year|Earnings growth in current year nuvalent.com|Earnings per share growth in current year Kymera (KYMR)|IDYA (IDEAYA Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year ELVN (Enliven Therapeutics Inc)|Net earnings per share change in current year ORIC Pharma|Relay Therapeutics Inc - Earnings growth in current year|Earnings per share growth rate in current year Tyra Biosciences|VSTM (Verastem, Inc.) - Net earnings per share growth this year|GLUE: Net earnings per one share growth for the current year|CGEM (cullinanoncology.com) - Earnings growth in current year|Earnings per share growth rate in current year Immuneering Inc. IMRX|Earnings growth in current year CCCC|Black Diamond Therapeutics - Earnings per share growth this year|Repare Therapeutics Inc. - Net earnings per share growth this year|Earnings per share increase in current year PMVP|KPTI: Net earnings per share growth this year|propanc.com - Net earnings per one share growth for the current year|BGMS: Earnings growth in current year|Aadi Bioscience Inc - Earnings per share increase in current year|ALRN (Aileron Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year blueprintmedicines.com BPMC|Earnings per share growth in current year GlycoMimetics Inc. (GLYC)|SWTX (SpringWorks) - Earnings per share increase in current year